CHE
Signal
Leaning Bullish1
Price
1
Move+0.14%Quiet session
Volume
1
Volume0.0× avgLight volume
Technical
1
RSIRSI 63Momentum positive
PRICE
Prev Close
422.16
Open
421.10
Day Range419.57 – 422.73
419.57
422.73
52W Range365.21 – 583.96
365.21
583.96
26% of range
VOLUME & SIZE
Avg Volume
266.9K
FUNDAMENTALS
P/E Ratio
23.1x
EPS (TTM)
Div Yield
0.00%
Beta
0.51
Low vol
Performance
1D
-0.66%
5D
+0.10%
1M
+9.27%
3M
-4.87%
6M
-3.86%
YTD
-1.33%
1Y
-26.72%
Best: 1M (+9.27%)Worst: 1Y (-26.72%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +2% YoY
Valuation
FAIR
P/E 23x vs ~20x sector
Health
MODERATE
CR 0.9 (low) · FCF $27.58/sh
Bullish
Key MetricsTTM
Market Cap$5.62B
Revenue TTM$2.54B
Net Income TTM$259.78M
Free Cash Flow$377.12M
Gross Margin30.3%
Net Margin10.2%
Operating Margin12.9%
Return on Equity25.3%
Return on Assets16.9%
Debt / Equity0.28
Current Ratio0.85
EPS TTM$19.00
Alpha SignalsFull Analysis →
What Moves This Stock

VITAS average daily census (ADC) growth and admission trends - organic growth typically 2-4% annually driven by aging demographics and market share gains from smaller hospice providers

Medicare reimbursement rate updates - annual market basket increases (typically 2-3%) directly impact 80% of revenue, with potential policy changes to hospice payment reform

VITAS length-of-stay and acuity mix - longer stays improve profitability but very long stays (180+ days) trigger Medicare cap exposure; routine home care mix optimization drives margin

Roto-Rooter same-store sales growth and commercial demand - residential demand relatively stable, commercial segment more cyclical and tied to construction activity and business investment

Macro Sensitivity
Economic Cycle

low - VITAS hospice services are non-discretionary end-of-life care with 90% Medicare funding, making revenue largely recession-resistant and driven by demographic trends rather than economic cycles. Roto-Rooter's residential emergency services (60-65% of segment revenue) are also non-discretionary, though commercial plumbing and elective residential projects show moderate sensitivity to business investment and consumer confidence. Overall company revenue demonstrates <5% correlation to GDP fluctuations.

Interest Rates

Rising rates have minimal direct impact given low leverage (0.13 debt/equity) and modest borrowing needs. However, higher rates can pressure valuation multiples for stable cash flow businesses, as investors compare yields to fixed income alternatives. VITAS expansion through tuck-in acquisitions (typical 6-8x EBITDA multiples for small hospice providers) becomes more expensive in higher rate environments. Roto-Rooter franchise expansion and housing turnover (which drives plumbing upgrades) show modest negative correlation to mortgage rates.

Key Risks

Medicare hospice payment reform risk - CMS has proposed changes to the two-tier payment system and potential caps on routine home care lengths-of-stay, which could compress margins if very long-stay patients (currently ~8-10% of census) face reimbursement reductions

Hospice industry consolidation and competitive intensity - private equity-backed roll-ups and national chains (Encompass Health, Amedisys) increasing competition for referrals from hospitals and physicians, potentially pressuring admission growth and requiring higher sales/marketing spend

Labor availability and wage inflation in healthcare - nursing and home health aide shortages in tight labor markets increase costs and limit census growth capacity, with wage pressures typically exceeding Medicare reimbursement rate increases by 100-200 basis points

Investor Profile

value/dividend - Attracts investors seeking defensive healthcare exposure with 1.0% dividend yield, consistent free cash flow generation (5.4% FCF yield), and modest growth (7-8% revenue CAGR). The combination of non-cyclical hospice revenue (80% of business) and essential services (Roto-Rooter) appeals to quality-focused value investors prioritizing capital returns and downside protection. Limited growth optionality versus high-growth healthcare peers, but superior cash generation and 24% ROE compensate through buybacks (company has reduced share count ~2% annually).

Watch on Earnings
Medicare hospice reimbursement rate changes (announced annually in August for October implementation) - market basket index typically tied to CPI-U hospital services componentVITAS average daily census growth rate and admission trends by major market (California, Florida, Texas, Ohio represent ~60% of census)VITAS average length-of-stay and median length-of-stay trends - optimal range 80-100 days balances revenue and cost efficiencyRoto-Rooter same-store sales growth and job count trends in company-owned branches
Health Radar
4 strong2 concern
64/100
Liquidity
0.85Concern
Leverage
0.28Strong
Coverage
94.4xStrong
ROE
25.3%Strong
ROIC
19.5%Strong
Cash
$75MConcern
ANALYST COVERAGE8 analysts
BUY
+12.4%upside to target
Buy
450%
Hold
450%
4 Buy (50%)4 Hold (50%)0 Sell (0%)
Full report →
Stock Health
Composite Score
4 of 5 signals bullish
8/10
Technicals
RSI RangeRSI 63 — Bullish momentum
Volume
Volume FlowAccumulation — institutional buying
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 0.85 — liquidity risk
Upcoming Events
EEarnings Report · After CloseMay 5, 2026
Tomorrow
DEx-Dividend DateAug 2, 2026
In 90 days
Technicals
Technical SetupBULLISH
Technicals →

Trend

RallyDeath Cross · 50D trails 200D by 5.4%

+2.6% vs SMA 50 · -2.9% vs SMA 200

Momentum

RSI62.8
Positive momentum, not extended
MACD+5.65
Above zero — bullish momentum · expanding
Market Position
Price Levels
52W High
$584.0+38.1%
EMA 200
$444.5+5.1%
Current
$422.7
EMA 50
$407.3-3.6%
52W Low
$365.2-13.6%
52-Week RangeMid-range
$365.226th %ile$584.0
Squeeze SetupVolume-based
Moderate Squeeze Setup

Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.

20-Day Money Flow
Acc days:6
Dist days:5
Edge:+1 acc
Volume Context
Avg Vol (50D)150K
Recent Vol (5D)
131K-13%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 3 analysts
Analyst revisions:EPS↑ Revised Up

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2023
$2.3B
$2.3B$2.3B
$19.93
±0%
Low1
FY2024
$2.4B
$2.4B$2.4B
+3.9%$23.08+15.8%
±0%
Low2
FY2025
$2.5B
$2.5B$2.6B
+5.0%$22.15-4.0%
±1%
Moderate3
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryCHE
Last 8Q
-2.1%avg beat
Beat 3 of 8 quartersMissed 5 Estimates falling
-2%
Q3'24
-2%
Q4'24
+1%
Q1'25
+1%
Q2'25
-11%
Q3'25
-2%
Q4'25
-9%
Q1'26
+7%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
Neutral — mixed activity
90d01
Bank of America Sec…Cautious
Feb 26
DOWNGRADE
JefferiesBuy → Hold
Jan 22
DOWNGRADE
JefferiesHold → Buy
Sep 2
UPGRADE
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
Mcnamara Kevin JDir
$554K
Mar 27
SELL
Mcnamara Kevin JDir
$806K
Mar 12
SELL
Mcnamara Kevin JDir
$875K
Nov 24
SELL
Mcnamara Kevin JDir
$1.4M
Sep 26
SELL
Grace Patrick PDir
$70K
Sep 9
SELL
Mcnamara Kevin JDir
$857K
Aug 5
SELL
Financials
Dividends0.54% yield
+26.1% avg annual growth
Annual Yield0.54%
Quarterly Div.$0.6000
Est. Annual / Share$2.40
FrequencyQuarterly
Q2'24
Q3'24
Q4'24
Q1'25
Q2'25
Q3'25
Q4'25
Q1'26

Dividend per payment — last 8 periods

INSTITUTIONAL OWNERSHIP

1
Boston Trust Walden Corp
205K
2
River Road Asset Management, LLC
72K
3
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/
62K
4
ProShare Advisors LLC
57K
5
RIVERBRIDGE PARTNERS LLC
51K
6
Candriam S.C.A.
43K
7
Retirement Systems of Alabama
38K
8
Nuveen, LLC
34K
News & Activity

CHE News

20 articles · 4h ago

About

chemed is a holding company. our wholly owned subsidiaries are vitas and roto-rooter services company. vitas is a healthcare company that specializes in hospice or end of life care for the terminally ill. roto-rooter is the nation's largest provider of plumbing and drain care services.

CEO
Kevin McNamara
Joel L. WherleyPresident & CEO of VITAS Healthcare
Brian C. JudkinsVice President, Secretary & Chief Legal Officer
Kevin J. McNamaraChief Executive Officer, President & Director
Peers(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
CHE
$422.73-0.66%$5.6B22.2+405.9%1048.4%1500
$404.56+0.00%$2.1T1500
$91.43+0.00%$316.0B14.11510.7%1500
$134.76+0.00%$305.1B23.71305.9%1500
$184.37+0.00%$286.4B27.2+862.9%1745.9%1500
$145.51+0.00%$279.7B21.0+597.3%2564.4%1500
$89.10+0.00%$251.9B14.4668.4%1500
Sector avg-0.09%20.4+622.0%1473.9%1500